MedPath

Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO
Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Associated Conditions
Agitation, Alcohol Withdrawal Syndrome
Associated Therapies
-

Comparison Between Dexmeditomidine, Midazolam and Ketamine as a Sedative to Help Cannula Insertion in Pediatric Patient

Phase 2
Completed
Conditions
Cannula Site Pain
Interventions
First Posted Date
2021-01-11
Last Posted Date
2021-05-28
Lead Sponsor
Ain Shams University
Target Recruit Count
150
Registration Number
NCT04704622
Locations
🇪🇬

Ain Shams University Hospital, Cairo, EL Abassia, Egypt

Effect of Anesthetic Drugs on Neurocognitive Function in Children With Retinoblastoma Requiring Multiple Anesthetic Exposure - Preliminary Study

Not Applicable
Recruiting
Conditions
Retinoblastoma
Interventions
First Posted Date
2021-01-08
Last Posted Date
2023-04-24
Lead Sponsor
Seoul National University Hospital
Target Recruit Count
60
Registration Number
NCT04700514
Locations
🇰🇷

Seoul National University Hospital, Seoul, Korea, Republic of

Comparison of Doses of Dexmedetomidine With Bupivacaine in Caudal Block for Duration of Analgesia in Paediatric Infraumblical Surgeries.

Phase 4
Conditions
Pain, Postoperative
Interventions
First Posted Date
2021-01-07
Last Posted Date
2021-01-07
Lead Sponsor
Dr. Ruth K.M. Pfau Civil Hospital, Karachi
Target Recruit Count
162
Registration Number
NCT04700228
Locations
🇵🇰

Dr. Haris Chohan, Karachi, Sindh, Pakistan

Dexmedetomidine Compared to Ketofol for Sedation in Paediatrics

Phase 1
Completed
Conditions
Vital Signs
Interventions
First Posted Date
2020-12-21
Last Posted Date
2022-08-05
Lead Sponsor
Ain Shams University
Target Recruit Count
40
Registration Number
NCT04678050
Locations
🇪🇬

Ain Shams University, Cairo, Abassia, Egypt

Dexmedetomidine Alleviates Postoperative Delirium After Brain Tumor Resections

Not Applicable
Completed
Conditions
Dexmedetomidine
Postoperative Delirium
Interventions
Drug: 0.9% saline
Drug: Dexmedetomidine
First Posted Date
2020-12-19
Last Posted Date
2022-04-04
Lead Sponsor
Beijing Tiantan Hospital
Target Recruit Count
260
Registration Number
NCT04674241
Locations
🇨🇳

PLA General Hospital, Beijing, China

🇨🇳

Beijing TianTan Hospital,Capital Medical University, Beijing, Beijing,China, China

Dexmedetomidine Facilitate Analgesia

Phase 4
Completed
Conditions
Lower Limb Fracture
Nerve Block
Interventions
First Posted Date
2020-12-19
Last Posted Date
2021-08-05
Lead Sponsor
China International Neuroscience Institution
Target Recruit Count
181
Registration Number
NCT04675372
Locations
🇨🇳

China International Neuroscience, Beijing, Beijing, China

Subtenon and Intravenous Dexmedetomidine Effect on Patients Undergoing Cataract Surgery

Phase 3
Conditions
Acute Postoperative Pain
Interventions
Drug: Dexmedetomidine
Drug: lidocaine 2%
Drug: bupivacine 0.5%
Drug: Normal saline
First Posted Date
2020-12-16
Last Posted Date
2021-02-25
Lead Sponsor
Menoufia University
Target Recruit Count
75
Registration Number
NCT04668456
Locations
🇪🇬

Sadik A Sadik, Shibīn Al Kawm, Menoufiya, Egypt

🇪🇬

Ashraf magdy Eskandr, Shibīn Al Kawm, Menoufiya, Egypt

🇪🇬

Osama A Elmorsy, Shibīn Al Kawm, Menoufiya, Egypt

Co-administration of Dexmedetomidine in Carotid Endarterectomy (CEA)

Phase 4
Completed
Conditions
Carotid Stenosis
Interventions
First Posted Date
2020-12-10
Last Posted Date
2020-12-19
Lead Sponsor
Insel Gruppe AG, University Hospital Bern
Target Recruit Count
23
Registration Number
NCT04662177
Locations
🇨🇭

Inselspital Bern, Bern, Switzerland

Neuroimaging Study of Dexmedetomidine-Induced Analgesia

Phase 2
Conditions
Anesthesia
Analgesia
Interventions
First Posted Date
2020-12-07
Last Posted Date
2022-03-31
Lead Sponsor
Massachusetts General Hospital
Target Recruit Count
20
Registration Number
NCT04656470
Locations
🇺🇸

Massachusetts General Hospital, Boston, Massachusetts, United States

Intranasal Dexmedetomidine Versus Intranasal Midazolam for MRI In Pediatrics

Phase 4
Completed
Conditions
Midazolam
MRI
Pediatrics
Dexmedetomidine
Interventions
First Posted Date
2020-12-03
Last Posted Date
2023-04-20
Lead Sponsor
Tanta University
Target Recruit Count
60
Registration Number
NCT04652661
Locations
🇪🇬

Tanta University Hospitals, Tanta, ElGharbiaa, Egypt

© Copyright 2025. All Rights Reserved by MedPath